Ceragenin Mediated Selectivity of Antimicrobial Silver Nanoparticles
Overview
Biotechnology
Authors
Affiliations
The understanding that common broad-spectrum antimicrobials disrupt natural microbial flora important in acquiring nutrients and preventing infection has resulted in a paradigm shift favoring more selective antimicrobials. This work explores silver nanoparticles conjugated with ceragenin, or cationic antimicrobials (CSA-SNPs), as a potential Gram-positive selective antimicrobial. Herein, CSA-SNPs are characterized using transmission electron microscopy (TEM), dynamic light scattering (DLS), zeta potential, and high-performance liquid chromatography-electrospray time-of-flight mass spectrometry (HPLC-ESI-TOF-MS). The antimicrobial properties are determined through minimum inhibitory concentration/minimum bactericidal concentration (MIC/MBC) and time-kill studies. Spatial selectivity of the conjugate nanoparticle was evaluated using confocal imaging, MATLAB statistical analysis, and video monitored interactions between bacteria and CSA-SNPs via laser trapping techniques. Cytotoxicity was also determined by live/dead staining and flow cytometry. Average particle size, as determined through TEM analysis, and hydrodynamic diameter, as determined via DLS, are 63.5 ± 38.8 and 102.23 ± 2.3 nm, respectively. The zeta potential of the SNP before and after CSA attachment is -18.23 and -8.34 mV, respectively. MIC/MBC data suggest that CSA-SNPs are 8 times more effective against Staphylococcus aureus than SNPs alone. Furthermore, MATLAB analysis of confocal imaging found that 70% of CSA-SNPs are within 2 μm of S. aureus, whereas this percentage falls to below 40% with respect to Escherichia coli. These results are bolstered further by laser trapping experiments demonstrating selective adherence of CSA-SNPs conjugates with bacterial strains. Cytotoxicity studies of CSA-SNPs against 3T3 fibroblasts indicate 50% cell viability at 50 ppm.
Nanomaterials and Coatings for Managing Antibiotic-Resistant Biofilms.
Ferreres G, Ivanova K, Ivanov I, Tzanov T Antibiotics (Basel). 2023; 12(2).
PMID: 36830221 PMC: 9952333. DOI: 10.3390/antibiotics12020310.
Kazakova O, Giniyatullina G, Babkov D, Wimmer Z Int J Mol Sci. 2022; 23(3).
PMID: 35162998 PMC: 8834734. DOI: 10.3390/ijms23031075.
Gibala A, Zeliszewska P, Gosiewski T, Krawczyk A, Duraczynska D, Szaleniec J Biomolecules. 2021; 11(10).
PMID: 34680114 PMC: 8533414. DOI: 10.3390/biom11101481.
Translation of ceragenin affinity for bacteria to an imaging reagent for infection.
Bandara N, Li Y, Diebolder P, Mpoy C, Gu X, Khanal P RSC Adv. 2020; 9(25):14472-14476.
PMID: 32864109 PMC: 7451630. DOI: 10.1039/c9ra02226k.
Scolari I, Paez P, Musri M, Petiti J, Torres A, Granero G Drug Deliv Transl Res. 2020; 10(5):1403-1417.
PMID: 32363536 DOI: 10.1007/s13346-019-00705-3.